IFN-α/β/IFN-γ/IL-15通路识别出具有免疫反应表型的GBP1表达瘤
Lei Wang1, Yuxuan Wei1, Zheng Jin2,3
1Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, People's Republic of China.
Clinical and experimental medicine
|May 17, 2024
概括
干扰素 (IFN) 和干扰素 (IL) -15 途径预测免疫治疗反应. 关氨酸结合蛋白1 (GBP1) 有效地代表了这些途径,并作为预测患者对癌症免疫疗法的反应的新生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 生物标志物发现发现
背景情况:
- 免疫疗法是癌症的关键治疗方法,但患者的反应各不相同.
- 预测免疫治疗的成功对于有效的治疗策略至关重要.
- CD8+ T细胞的反应对于抗瘤免疫力和免疫疗法的有效性至关重要.
研究的目的:
- 为了调查干扰素 (IFN) -α/β/IFN-γ/干扰素 (IL) -15途径是否可以预测免疫治疗反应.
- 识别代表这些途径的潜在生物标志物,用于响应预测.
- 探索瘤微环境中已识别的生物标志物的功能作用.
主要方法:
- 对多个公共癌症免疫疗法数据库的分析.
- 在公共和私人患者队列中验证途径和生物标志物性能.
- 研究生物标志物表达和与免疫细胞相关因素的相关性.
主要成果:
- IFN-α/β/IFN-γ/IL-15通路显著预测免疫治疗反应.
- 关酸结合蛋白1 (GBP1) 有效地代表了这些IFN/IL通路.
- 巨细胞中的GBP1表达与T细胞迁移至关重要的化学因相关.
结论:
- 1英是免疫治疗反应的强有力的预测指标.
- 1英可以作为癌症免疫治疗的新型预测生物标志物.
- 1英代表了提高免疫疗法疗效的潜在治疗标.
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...


